IKS applies laboratory expertise to motorcycling
Sets up racing team and uses XiltriX to monitor racing performance of rider Mervyn Verploegen
According to IKS md Stephen Tierney, this is not just the usual sponsorship arrangement: IKS will be applying the expertise accumulated in more than 20 years of laboratory monitoring to improve racing performance.
‘We’re delighted to be able to help this young talent advance his sporting career and to support his family, who are very much involved,’ he said. ‘Unusually in such situations, though, we can also contribute technically by applying the technology employed in our XiltriX laboratory monitoring systems to measuring parameters such as tyre temperature and pressure that have a significant impact on racing performance.’
He added: ‘Motor racing is pure adrenaline, but control is vital: our traditional markets are rather more conservative and sometimes slow moving, but control is every bit as important. We like to think that being involved in two such different environments will help develop the progressive and innovative philosophy that will drive our company forward.’
IKS International, based in Rosmalen, near 's-Hertogenbosch, supplies advanced products and services to clinical, biotechnology, pharmaceutical and microbiology laboratories worldwide.
You may also like
Manufacturing
Nulogy launches Supplier Compliance Management to build stronger, more resilient supplier networks
Nulogy, a leading provider of manufacturing operations software, announced the launch of Nulogy Supplier Compliance Management, a solution designed to centralise and automate supplier compliance for procurement, supply chain, and quality assurance teams in manufacturing, food & beverage, pharmaceuticals, and
other highly regulated industries
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Finance
Investing in the future of healthcare: from diagnostics innovation to scientific talent pipelines
Strategic UK investment in next-generation cancer diagnostics and cardiovascular research training is accelerating innovation, reducing barriers to adoption and building the multidisciplinary talent needed to deliver long-term improvements in patient outcomes and life sciences growth